Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Vilon

KE, L-Lys-L-Glu, lysylglutamic acid

Quick Stats
Studies 40
Trials 100
Score 1
2002 pubmed

[Characteristics of effect of ultralow doses of vilon in organotypic culture of spleens from rats of various ages].

Bykov. N M NM; Chalisova. N I NI

Key Findings

  • Ultralow doses of vilon (10⁻⁹‑10⁻¹³ M) altered spleen tissue development in culture
  • The effect was seen in spleens from rats of different ages, including older ones
  • Authors suggest the finding could be explored for geriatric therapy

Practical Outcomes

  • At this point there’s no actionable protocol for humans—more animal and clinical research is needed before biohackers could consider using vilon for longevity or immune health.

Summary

The study looked at tiny amounts of a peptide called vilon on rat spleen tissue grown in the lab and found that even extremely low concentrations seemed to change how the tissue grew, especially in older rats, hinting it might one day be useful for anti‑aging treatments, but it’s only an early‑stage animal experiment.

Abstract

There was studied the effect of vilon ultrasmall dose in the spleen organotypic tissue culture of rats of various age. The data obtained suggest that vilon ultrasmall dose (10(-9)-10(-13) M) exerted expressive effect on the explants development. This effect of effect of vilon ultrasmall dose can be used by the therapy, namely in the geriatric practice.

Study Information

Provider

pubmed

Year

2002